Evolent Health Inc [NYSE: EVH] price surged by 4.50 percent to reach at $0.44.
A sum of 4727321 shares traded at recent session while its average daily volume was at 2.56M shares. Evolent Health Inc shares reached a high of $10.31 and dropped to a low of $9.63 until finishing in the latest session at $10.21.
The one-year EVH stock forecast points to a potential upside of 32.96. The average equity rating for EVH stock is currently 1.14, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Evolent Health Inc [EVH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EVH shares is $15.23 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EVH stock is a recommendation set at 1.14. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Evolent Health Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 10, 2025. While these analysts kept the previous recommendation, BTIG Research dropped their target price from $36 to $29. The new note on the price target was released on December 03, 2024, representing the official price target for Evolent Health Inc stock. Previously, the target price had yet another drop from $38 to $16, while Stephens kept a Equal-Weight rating on EVH stock.
The Price to Book ratio for the last quarter was 1.26, with the Price to Cash per share for the same quarter was set at 2.24.
EVH Stock Performance Analysis:
Evolent Health Inc [EVH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -10.75. With this latest performance, EVH shares dropped by -2.76% in over the last four-week period, additionally plugging by 0.39% over the last 6 months – not to mention a drop of -9.24% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EVH stock in for the last two-week period is set at 47.57, with the RSI for the last a single of trading hit 0.61, and the three-weeks RSI is set at 0.57 for Evolent Health Inc [EVH]. The present Moving Average for the last 50 days of trading for this stock 9.51, while it was recorded at 10.11 for the last single week of trading, and 12.12 for the last 200 days.
Insight into Evolent Health Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Evolent Health Inc [EVH] shares currently have an operating margin of -0.07% and a Gross Margin at 10.52%. Evolent Health Inc’s Net Margin is presently recorded at -5.86%.
Evolent Health Inc (EVH) Capital Structure & Debt Analysis
According to recent financial data for Evolent Health Inc. ( EVH), the Return on Equity (ROE) stands at -10.99%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -4.11%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Evolent Health Inc’s Return on Invested Capital (ROIC) is -7.84%, showcasing its effectiveness in deploying capital for earnings.
Evolent Health Inc (EVH) Efficiency & Liquidity Metrics
Based on Evolent Health Inc’s (EVH) latest financial statements, the Debt-to-Equity Ratio is 1.14%, indicating its reliance on debt financing relative to shareholder equity.
Evolent Health Inc (EVH) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Evolent Health Inc. (EVH) effectively leverages its workforce, generating an average of -$31217.78 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.98% and a Quick Ratio of 0.98%, indicating strong ability to cover short-term liabilities.
EVH Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EVH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Evolent Health Inc go to 24.52%.
Evolent Health Inc [EVH] Institutonal Ownership Details
There are presently around $108.63%, or 110.33% of EVH stock, in the hands of institutional investors. The top three institutional holders of EVH stocks are: WELLINGTON MANAGEMENT GROUP LLP with ownership of 11.17 million shares, which is approximately 9.7383%. VANGUARD GROUP INC, holding 11.06 million shares of the stock with an approximate value of $$211.39 million in EVH stocks shares; and VANGUARD GROUP INC, currently with $$166.1 million in EVH stock with ownership which is approximately 7.5745%.